Nima Moaven

A New Glucocerebrosidase Chaperone Reduces α-Synuclein and Glycolipid Levels in iPSC-Derived Dopaminergic Neurons from Patients with Gaucher Disease and Parkinsonism

Zayd M. Khaliq, Wei Zheng, J. Marugan, 2016, The Journal of Neuroscience.

Lysosomal storage and impaired autophagy lead to inflammasome activation in Gaucher macrophages

J. Marugan, W. Westbroek, G. Lopez, 2015, Aging cell.

A mutation in SCARB2 is a modifier in gaucher disease

W. Westbroek, E. Sidransky, O. Goker-Alpan, 2011, Human mutation.

Complexity of Genotype-Phenotype Correlations in Mendelian Disorders: Lessons from Gaucher Disease

E. Sidransky, N. Tayebi, E. Goldin, 2015 .

Identification of miRNAs that modulate glucocerebrosidase activity in Gaucher disease cells

W. Westbroek, E. Sidransky, M. Saraiva-Pereira, 2014, RNA biology.

α-Synuclein Interacts with Glucocerebrosidase Providing a Molecular Link between Parkinson and Gaucher Diseases*

Jennifer C. Lee, W. Westbroek, E. Sidransky, 2011, The Journal of Biological Chemistry.

Macrophage Models of Gaucher Disease for Evaluating Disease Pathogenesis and Candidate Drugs

A. Dutra, Noel Southall, Wei Zheng, 2014, Science Translational Medicine.

A mutation in SCARB2 is a modifier in gaucher disease

W. Westbroek, E. Sidransky, O. Goker-Alpan, 2011, Human mutation.